A

Active Director Director DIN 08725707
DIN 08725707 First appointment Mar 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2020
Shareholding value •••• Premium profile

About Anupama

Data last updated:

Anupama is a Director at Biovitamins Private Limited (since 2020). The company operates in Pharma. Biovitamins Private Limited reported revenue of ₹24.97 Cr (FY 2025).

DIN 08725707
Primary Designation Director
Industry Pharma
First Appointment 14 Mar 2020
Oldest Company Age 24 yrs
Largest company Biovitamins Private Limited · ₹24.97 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biovitamins Private Limited U24234KA2002PTC030453
Director14 Mar 20202002₹24.97 Cr (FY 2025)Active

Board colleagues of Anupama

NameDINCompanyDesignation
Yelavarthi Narasaraju Kumaraswamy Raju01123742Biovitamins Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Biovitamins Private Limited
Premium access

Shareholding and investment profile for Anupama

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anupama

Anupama currently holds 1 directorship: Biovitamins Private Limited (Director, since 14 Mar 2020, revenue ₹24.97 Cr (FY 2025)).

Anupama was first appointed on 14 Mar 2020 as Director at Biovitamins Private Limited.

The current boards of Anupama's companies include Yelavarthi Narasaraju Kumaraswamy Raju (Biovitamins Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available